drug substance development

Showing 1 posts of 1 posts found.

Ofichem acquires US drug substance CDMO Kinentia

October 14, 2026
Biotechnology, CDMO, Pharmacy, acquisitions, drug substance development

Ofichem has agreed to acquire Kinentia Biosciences, a US drug substance contract development and manufacturing organisation (CDMO), in a deal …

The Gateway to Local Adoption Series

Latest content